But that’s our role as shareholders to help fund teams/projects
I supported the cap raise at 17c - the purpose of that raise was to advance RP-11/platform to market - was expecting the ramp up of staff.
We help sow into their opportunity to do some really important/exciting science - and PYC/patients has the opportunity to reap rewards/hope if successful.
Worth remembering the probability of success is not affected by the mood of the market/share price, but the determination/ /efforts and quality of output by the team of 70.
But that’s our role as shareholders to help fund teams/projects...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.3¢ | 12.0¢ | $624.5K | 5.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1227634 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 130000 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |